Lv21
130 积分 2023-12-06 加入
Transcellular stomach absorption of a derivatized glucagon-like peptide-1 receptor agonist
7小时前
已完结
Clinical Pharmacokinetics of Dulaglutide in Patients with Type 2 Diabetes: Analyses of Data from Clinical Trials
20天前
已完结
Dozens of new obesity drugs are coming: these are the ones to watch
20天前
已完结
A Quantitative Prediction Method for the Human Pharmacokinetics of Fc-Fusion Proteins
29天前
已完结
Current status and future perspectives of FGF21 analogues in clinical trials
1个月前
已完结
A phase 1, randomized, double‐blind, placebo‐controlled trial investigating the pharmacokinetics, pharmacodynamics, safety and tolerability of oral semaglutide in healthy Chinese subjects
2个月前
已完结
Phase I results for AMG 133
4个月前
已完结
A model‐based approach to predict individual weight loss with semaglutide in people with overweight or obesity
4个月前
已完结
Population Pharmacokinetics of Liraglutide, a Once‐Daily Human Glucagon‐Like Peptide‐1 Analog, in Healthy Volunteers and Subjects With Type 2 Diabetes, and Comparison to Twice‐Daily Exenatide
5个月前
已完结
Clinical Pharmacokinetics of Dulaglutide in Patients with Type 2 Diabetes: Analyses of Data from Clinical Trials
5个月前
已完结
皖公网安备34019202002308
